Nexviadyme 100 mg
Nexviadyme 100 mg is a medicine authorised by Swissmedic under authorisation number 67871. The authorisation holder is Sanofi-Aventis (Suisse) SA. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 17 November 2021 and the authorisation is valid without a time limit. ATC code A16AB22 places the medicine in the group Other alimentary tract and metabolism products.
| Authorisation number | 67871 |
|---|---|
| Name | Nexviadyme 100 mg |
| Full name | Nexviadyme 100 mg, poudre pour solution à diluer pour perfusion |
| Authorisation holder | Sanofi-Aventis (Suisse) SA |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | A16AB22 |
| First authorisation | 17 November 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Nexviadyme 100 mg, poudre pour solution à diluer pour perfusion | A | 17 November 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | A16AB22 | 07.14.0. | A |
| 2 | 5 | Durchstechflasche(n) | A16AB22 | 07.14.0. | A |
| 3 | 10 | Durchstechflasche(n) | A16AB22 | 07.14.0. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Nexviadyme 100 mg authorised in Switzerland?
Yes. Nexviadyme 100 mg is authorised by Swissmedic under authorisation number 67871, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Nexviadyme 100 mg have?
Nexviadyme 100 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Nexviadyme 100 mg?
The authorisation holder is Sanofi-Aventis (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.